Stay updated on Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial

Sign up to get notified when there's something new on the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; this minor version change does not affect page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:15:35.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Added a Locations section with a Texas site; removed the Texas Locations section and the HHS Vulnerability Disclosure link, and updated the revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T10:22:31.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    An editorial note was added that publications are automatically filled from PubMed, and the page revision was updated to v3.3.2. The previous wording about PubMed publications and automatic listing by ClinicalTrials.gov was removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:44:33.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The government funding/operation status notice has been removed from the page, leaving the focus on the study details and related information.
    Difference
    0.3%
    Check dated 2025-11-17T17:28:49.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    No significant changes were detected. The Study Details page remains the same in content and layout.
    Difference
    0.3%
    Check dated 2025-11-03T11:41:45.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T17:18:40.000Z thumbnail image

Stay in the know with updates to Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Idarubicin, Cytarabine, Nivolumab in MDS/AML Clinical Trial page.